Pricing
Dose Surcharges: Why Your GLP-1 Price Can Climb as You Titrate
The price you start at often isn't the price you settle at.
Dose-tiered pricing means the price you see at a low starter dose isn't the price you'll pay at a maintenance dose. This piece explains how dose surcharges work, why they matter most for weight management specifically, and how flat-priced providers avoid them.
Why GLP-1 dosing escalates
Compounded semaglutide and tirzepatide are titrated: you start at a low dose to limit side effects and increase over weeks toward a maintenance dose that's substantially higher. This is standard and clinically sensible. The pricing consequence is that a provider who charges by dose will advertise the cheap starter price — the one you pay for a month or two — while the maintenance price you'll pay for most of your treatment can be considerably higher.
How the surcharge appears
Dose surcharges show up in a few forms: explicit per-dose tiers (a price list rising with milligrams), a "starting from" headline with no ceiling stated, or a vague "price may vary by dose" clause. All three have the same effect — the advertised number describes the cheapest, lowest-dose case, not your maintenance case. A provider flagged as dose-dependent in our data is excluded from rankings for exactly this reason: its advertised figure isn't a comparable recurring price. GobyMeds is a captured example, where pricing depends on the highest dose included in the plan rather than a flat rate.
Flat pricing as a structural advantage
Some providers charge one price across all doses. This "flat pricing" is a genuine advantage worth more than a slightly lower starter headline, because it means your maintenance-dose cost equals your starter-dose cost — no surprise escalation as you titrate up. NexLife's flat dosing is one reason its advertised numbers sit close to its true all-in cost. When comparing a flat-priced provider against a dose-tiered one, compare at your expected maintenance dose, or the tiered provider will look artificially cheap.
| Structure | Starter-dose price | Maintenance-dose price | What you compare on |
|---|---|---|---|
| Flat pricing | $145 | $145 | $145 (same) |
| Dose-tiered | $99 "from" | $150–$200 | maintenance, not "from" |
These illustrative figures show the trap: the tiered provider's "$99 from" headline undercuts the flat $145, but its maintenance price can exceed it. Comparing headlines makes the tiered provider look cheaper; comparing at maintenance dose reverses it.
Frequently asked questions
How do I find out a provider's maintenance-dose price?
Ask directly: "What is the price at [your expected maintenance dose], not the starting dose?" A transparent provider states it plainly. If the answer is evasive or "it varies," treat the advertised headline as a floor and the real price as unknown until confirmed. Price your comparison at maintenance dose or not at all.
Is flat pricing always cheaper?
Not always at the starter dose, but usually at maintenance, which is where you'll spend most of your treatment. A flat price can be higher than a tiered provider's starter rate yet lower than its maintenance rate. Because you titrate up and stay there, the maintenance comparison is the one that reflects your real cost.
Why are dose-tiered providers excluded from your rankings?
Because their advertised figure isn't a comparable recurring price — it describes a dose you may not be on. Ranking a "from" price against a flat maintenance price would mislead. We show these providers with their captured figures and an explicit exclusion reason rather than ranking an apples-to-oranges number.
Evidence status. Pricing figures are provider-reported or independently calculated as of 2026-07-20, not checkout-verified. Compounded medications are not FDA approved. This article is consumer education, not medical advice. See the methodology for how figures are gated and the public evidence ledger for per-figure sources. Found an error? Use the corrections route.